Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Axil Brands (AXIL) EPS (Weighted Average and Diluted) (2022 - 2026)

Axil Brands (AXIL) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with $0.02 as the latest value for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) fell 71.43% to $0.02 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $0.12 through Feb 2026, down 47.83% year-over-year, with the annual reading at $0.1 for FY2025, 52.38% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.02 at Axil Brands, down from $0.09 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.1 in Q2 2024, with the low at -$0.03 in Q2 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.03, with a median of $0.03 recorded in 2026.
  • The sharpest move saw EPS (Weighted Average and Diluted) surged 2438.13% in 2023, then tumbled 300.0% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $0.0 in 2022, then soared by 2438.13% to $0.05 in 2023, then skyrocketed by 60.0% to $0.08 in 2024, then rose by 12.5% to $0.09 in 2025, then plummeted by 77.78% to $0.02 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.02, $0.09, and $0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.